Delfi Diagnostics
Biotechnology company developing blood tests for early cancer detection using fragmentomics - analyzing patterns in cell-free DNA fragments to detect cancer at its earliest, most treatable stages.
Location
Baltimore, Maryland, USA
Founded
2019
Investors
1
Categories
diagnostics, cancer-detection, liquid-biopsy, early-detection, genomics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |